WebDisclosure WebDisclosure
Basculer en Français
10827 Companies
234901 Keywords
163761 Articles
125734 Press releases
Headlines Articles Press releases EAN Congress Remove
  1. Home
  2. Companies
  3. EAN Congress
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/27/2026 at 00:10, 1 month 16 days ago

    Use of Hearing Aids Linked to Lower Dementia Risk in Epilepsy Patients

    Epilepsy Health Research Dementia Risk Hearing Aids Cognitive Reserve
  • BRIEF

    published on 06/27/2026 at 00:10, 1 month 16 days ago

    L'utilisation d'appareils auditifs est associée à un risque moindre de démence chez les patients épileptiques.

    Épilepsie Risque De Démence Appareils Auditifs Réserve Cognitive Recherche En Santé
  • PRESS RELEASE

    published on 06/27/2026 at 00:05, 1 month 16 days ago

    EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss

    Study presented at EAN Congress 2026 suggests hearing aid use may reduce dementia risk by 23% in people with epilepsy and hearing loss due to differences in cognitive reserve. Important clinical implications highlighted
    Epilepsy Hearing Aid Dementia Risk Cognitive Reserve EAN Congress
    Logo of EAN Congress
Accesswire
  • Published on 08/13/2026 at 00:30, 31 minutes ago

    Aton Closes CAD$4 Million Private Placement

  • Published on 08/12/2026 at 23:30, 1 hour 31 minutes ago

    CCL Industries Announces Record Results for 2026 Second Quarter

  • Published on 08/12/2026 at 23:30, 1 hour 31 minutes ago

    Bolt Metals to Rebrand as 26 Metals Inc. and Adopt the Ticker "IRON," Highlighting Its Focus on Flagship Florália Iron Project in Brazil's Iron Quadrangle

  • Published on 08/12/2026 at 23:20, 1 hour 41 minutes ago

    RJK Explorations Ltd. Announces Upsize of Previously Announced Private Placement

  • Published on 08/12/2026 at 23:05, 1 hour 56 minutes ago

    Vox Royalty Reports Q2 2026 Results And Declares Quarterly Dividend

View all ACCESSWIRE
EQS Group
  • Published on 08/12/2026 at 21:05, 3 hours 56 minutes ago

    Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA

  • Published on 08/12/2026 at 19:57, 5 hours 4 minutes ago

    EQS-Adhoc: Hypoport SE: Hypoport SE resolves share buyback programme with a volume of up to EUR 10 million

  • Published on 08/12/2026 at 19:37, 5 hours 24 minutes ago

    EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged

  • Published on 08/12/2026 at 18:50, 6 hours 11 minutes ago

    Holding(s) in Company

  • Published on 08/12/2026 at 18:29, 6 hours 32 minutes ago

    Designated Persons Notifications

View all EQS
Les Echos
  • Published on 08/11/2026 at 17:45, 1 day 7 hours ago

    DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026

  • Published on 08/11/2026 at 17:40, 1 day 7 hours ago

    Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions

  • Published on 08/10/2026 at 18:00, 2 days 7 hours ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026

  • Published on 08/10/2026 at 18:00, 2 days 7 hours ago

    AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026

  • Published on 08/10/2026 at 17:45, 2 days 7 hours ago

    Weekly share buyback

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy